Global Skin and Subcutaneous Tissue Diseases Mortality by Country

The global skin and subcutaneous tissue diseases mortality rates exhibit significant variance by country. Argentina and South Africa have higher rates compared to other regions, reflecting a notable healthcare challenge. On the contrary, countries like Slovenia, Romania, and Finland show remarkably lower rates. Over the last year, Poland experienced a significant rise, while Slovenia saw a notable decrease. In the last five years, Luxembourg shows a remarkable average annual growth in mortality rates, while Slovenia sees the steepest decline. Overall, European countries tend to have lower mortality rates, with developed nations showing minimal variations.

Future trends to watch include potential increases in mortality rates in developing regions and continued improvement and stabilization in developed countries. As global awareness and healthcare interventions grow, there may be an opportunity to address disparities and improve outcomes, especially in countries with higher rates. Innovations in healthcare technology and preventative measures are likely to play a key role in reducing mortality rates globally.

Top countries in Skin and Subcutaneous Tissue Diseases Mortality by Country

# 10 Countries Units (Deaths) Per Hundred Thousand Persons, Standardised Rates Last Year YoY 5-years CAGR
1 1 Argentina 10.2 2023 +6.25% +2.09% View data
2 2 South Africa 9.4 2023 +1.08% +1.1% View data
3 3 Brazil 7.7 2023 +4.05% +6.2% View data
4 4 Colombia 6.6 2023 0% +6.58% View data
5 5 Peru 5.9 2023 +7.27% +1.79% View data
6 6 Slovakia 4.6 2023 +2.22% +1.36% View data
7 7 Costa Rica 4.4 2023 +7.32% -1.31% View data
8 8 Latvia 3 2023 0% -3.58% View data
9 9 Spain 3 2023 +3.45% +1.39% View data
10 10 United Kingdom 3 2023 0% -0.65% View data

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease